These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 25449644)
1. Efficacy and safety of phenylephrine 2.5% with cyclopentolate 0.5% for retinopathy of prematurity screening in 1246 eye examinations. Neffendorf JE; Mota PM; Xue K; Hildebrand GD Eur J Ophthalmol; 2015; 25(3):249-53. PubMed ID: 25449644 [TBL] [Abstract][Full Text] [Related]
2. Randomised controlled pilot trial comparing low dose and very low- dose microdrop administration of phenylephrine and cyclopentolate for retinopathy of prematurity eye examinations in neonates. Kremer LJ; Broadbent R; Medlicott N; Sime MJ; McCaffrey F; Reith DM Arch Dis Child; 2021 Jun; 106(6):603-608. PubMed ID: 33051215 [TBL] [Abstract][Full Text] [Related]
3. Fatal necrotising enterocolitis due to mydriatic eye drops. Ozgun U; Demet T; Ozge KA; Zafer D; Murat S; Mehmet Y; Nilgun K J Coll Physicians Surg Pak; 2014 May; 24 Suppl 2():S147-9. PubMed ID: 24906272 [TBL] [Abstract][Full Text] [Related]
4. Transient paralytic ileus following the use of cyclopentolate-phenylephrine eye drops during screening for retinopathy of prematurity. Lim DL; Batilando M; Rajadurai VS J Paediatr Child Health; 2003; 39(4):318-20. PubMed ID: 12755944 [TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial to determine the lowest effective dose for adequate mydriasis in premature infants. Vicente GV; Bahri M; Palafoutas JJ; Wang H; Mehta N J AAPOS; 2012 Aug; 16(4):365-9. PubMed ID: 22929451 [TBL] [Abstract][Full Text] [Related]
6. Comparison of mydriatic regimens used in screening for retinopathy of prematurity in preterm infants with dark irides. Chew C; Rahman RA; Shafie SM; Mohamad Z J Pediatr Ophthalmol Strabismus; 2005; 42(3):166-73. PubMed ID: 15977870 [TBL] [Abstract][Full Text] [Related]
7. Pupil dilatation after single and triple doses of mydriatic agent in preterm infants. Punyawattanaporn A; Tengtrisorn S; Sangsupawanich P J Med Assoc Thai; 2009 Nov; 92(11):1458-62. PubMed ID: 19938737 [TBL] [Abstract][Full Text] [Related]
8. Combination cyclopentolate and phenylephrine for mydriasis in premature infants with heavily pigmented irides. Khoo BK; Koh A; Cheong P; Ho NK J Pediatr Ophthalmol Strabismus; 2000; 37(1):15-20. PubMed ID: 10714690 [TBL] [Abstract][Full Text] [Related]
9. Combination of 5% phenylephrine and 0.5% tropicamide eyedrops for pupil dilation in neonates is twice as effective as 0.5% tropicamide eyedrops alone. Lux AL; Degoumois A; Barjol A; Mouriaux F; Denion E Acta Ophthalmol; 2017 Mar; 95(2):165-169. PubMed ID: 27519933 [TBL] [Abstract][Full Text] [Related]
10. Transient ileus associated with the use of mydriatics after screening for retinopathy of prematurity in a very low birth weight infant. Degirmencioglu H; Oncel MY; Calisici E; Say B; Uras N; Dilmen U J Pediatr Ophthalmol Strabismus; 2014 Jul; 51 Online():e44-7. PubMed ID: 25003832 [TBL] [Abstract][Full Text] [Related]
11. Cardiopulmonary arrest following administration of Cyclomydril eyedrops for outpatient retinopathy of prematurity screening. Lee JM; Kodsi SR; Gaffar MA; Rubin SE J AAPOS; 2014 Apr; 18(2):183-4. PubMed ID: 24698618 [TBL] [Abstract][Full Text] [Related]
12. Systemic Absorption of Cyclopentolate and Adverse Events After Retinopathy of Prematurity Exams. Mitchell A; Hall RW; Erickson SW; Yates C; Lowery S; Hendrickson H Curr Eye Res; 2016 Dec; 41(12):1601-1607. PubMed ID: 27159349 [TBL] [Abstract][Full Text] [Related]
13. Alternative mydriasis techniques for retinopathy of prematurity screening. Seliniotaki AK; Prousali E; Lithoxopoulou M; Kokkali S; Ziakas N; Soubasi V; Mataftsi A Int Ophthalmol; 2020 Dec; 40(12):3613-3619. PubMed ID: 32772218 [TBL] [Abstract][Full Text] [Related]
14. Low dose or very low dose phenylephrine and cyclopentolate microdrops for retinopathy of prematurity eye examinations (The Little Eye Drop Study): a randomised controlled non-inferiority trial. Kremer LJ; Medlicott N; Sime MJ; Broadbent R; Edmonds L; Berry MJ; Austin NC; Alsweiler JM; Reith DM Arch Dis Child Fetal Neonatal Ed; 2023 Jul; 108(4):380-386. PubMed ID: 36593111 [TBL] [Abstract][Full Text] [Related]
15. The influence of drop size of cyclopentolate, phenylephrine and tropicamide on pupil dilatation and systemic side effects in infants. Elibol O; Alçelik T; Yüksel N; Caglar Y Acta Ophthalmol Scand; 1997 Apr; 75(2):178-80. PubMed ID: 9197568 [TBL] [Abstract][Full Text] [Related]
16. Reduction in mydriatic drop size in premature infants. Wheatcroft S; Sharma A; McAllister J Br J Ophthalmol; 1993 Jun; 77(6):364-5. PubMed ID: 8318484 [TBL] [Abstract][Full Text] [Related]
17. [Serious adverse side effects after pupillary dilation in preterm infants]. Lux AL; Mouriaux F; Guillois B; Fedrizzi S; Peyro-Saint-Paul L; Denion E J Fr Ophtalmol; 2015 Mar; 38(3):193-8. PubMed ID: 25726252 [TBL] [Abstract][Full Text] [Related]
18. Effects and side effects of mydriatic eyedrops in neonates. Oğüt MS; Bozkurt N; Ozek E; Birgen H; Kazokoğlú H; Oğüt M Eur J Ophthalmol; 1996; 6(2):192-6. PubMed ID: 8823596 [TBL] [Abstract][Full Text] [Related]
19. A mydriatic eye-drop combination without systemic effects for premature infants: a prospective double-blind study. Bolt B; Benz B; Koerner F; Bossi E J Pediatr Ophthalmol Strabismus; 1992; 29(3):157-62. PubMed ID: 1432499 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the effectiveness of mydriasis by two instillation methods of combined 0.75% tropicamide and 2.5% phenylephrine eye drop in preterm infants. Phamonvaechavan P; Chutasmit K; Damrongrak P; Koukiatkul S; Wongkiatkajorn T; Ngerncham S J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S1-7. PubMed ID: 22696845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]